Aditxt, Inc.
- ADTX
- OTC
- Biotechnology
- Immune Profiling
- Immunotherapy/Reprogramming
$0.00
Today −16.67%Quote Oct 19, 2026, 07:04 PM UTC
−75.00%over the last month
Max drawdown −75.0%From 1-month high −75.0%3 months −55.2%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Aditxt
Aditxt, Inc. is a biotechnology firm dedicated to advancing immune system health through innovative mapping and reprogramming techniques. The company's developments include AditxtScore, a platform designed to empower individuals by providing insights into their immune profiles for better management and informed awareness of immune system attacks or dysfunctions.
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Employees
26
Market value
$815.921
Quote Oct 19
Analyst target
$1280.00
+127999900.0% from here
Resistance
$0.00
50.0% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ADTXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free